Jilin Aodong Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 4/6
Jilin Aodong Pharmaceutical Group has a total shareholder equity of CN¥28.6B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 7.4%. Its total assets and total liabilities are CN¥33.4B and CN¥4.8B respectively.
Key information
7.4%
Debt to equity ratio
CN¥2.11b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥3.26b |
| Equity | CN¥28.62b |
| Total liabilities | CN¥4.80b |
| Total assets | CN¥33.42b |
Recent financial health updates
No updates
Recent updates
A Look At The Intrinsic Value Of Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)
Aug 22
Jilin Aodong Pharmaceutical Group (SZSE:000623) Is Increasing Its Dividend To CN¥0.60
Jul 05Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)
Jun 03There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings
Apr 23Financial Position Analysis
Short Term Liabilities: 000623's short term assets (CN¥6.1B) exceed its short term liabilities (CN¥3.5B).
Long Term Liabilities: 000623's short term assets (CN¥6.1B) exceed its long term liabilities (CN¥1.3B).
Debt to Equity History and Analysis
Debt Level: 000623 has more cash than its total debt.
Reducing Debt: 000623's debt to equity ratio has reduced from 9.3% to 7.4% over the past 5 years.
Debt Coverage: 000623's debt is not well covered by operating cash flow (15.8%).
Interest Coverage: Insufficient data to determine if 000623's interest payments on its debt are well covered by EBIT.